glp-1 and mcas GLP-1: Genetic Variants Related to RA Medications A newly published case series
Description
In the U.S., this can be done through the FDAs MedWatch program
GLP-1 RA T2D market (~4.5 yrs post-launch)
UA has also received investigator-led funding by Procter & Gamble
Preclinical studies in rodents consistently show reduced alcohol intake with GLP-1 medications, but human clinical trials have produced mixed results
Manufacturer Suggested Use: Take 1 teaspoon by mouth twice daily and hold for 30-90 seconds before swallowing
Weight reduction decreases lean and fat mass, influencing thyroid hormone distribution, and may lower levothyroxine requirements [64]
